Drug dosing in hospitalized obese patients with COVID-19

Obesity is highly prevalent in hospitalized patients admitted with COVID-19. Evidence based guidelines are available for COVID-19-related therapies but dosing information specific to patients with obesity is lacking. Failure to account for the pharmacokinetic alterations that exist in this populatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Barletta, Jeffrey F., Erstad, Brian L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919144/
https://www.ncbi.nlm.nih.gov/pubmed/35287690
http://dx.doi.org/10.1186/s13054-022-03941-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919144/
https://www.ncbi.nlm.nih.gov/pubmed/35287690
http://dx.doi.org/10.1186/s13054-022-03941-1

Ejemplares similares